Full case includes Shepard's, Headnotes, Legal Analytics from Lex Machina, and more.
2020 U.S. App. LEXIS 14696 *; 958 F.3d 1171; 2020 U.S.P.Q.2D (BNA) 10493
EAGLE PHARMACEUTICALS INC., Plaintiff-Appellant v. SLAYBACK PHARMA LLC, Defendant-Appellee
Subsequent History: Counsel Amended May 12, 2020.
Prior History: [*1] Appeal from the United States District Court for the District of Delaware in No. 1:18-cv-01953-CFC, United States District Judge Colm F. Connolly.
Eagle Pharms., Inc. v. Slayback Pharma LLC, 382 F. Supp. 3d 341, 2019 U.S. Dist. LEXIS 78146 (D. Del., May 9, 2019)
ethanol, patents, disclose, specification, district court, pharmaceutically, pleadings, infringement, formulations, skilled, doctrine of equivalents, disclosure-dedication, artisan, fluid, invention, glycol, antioxidant, disclosure, embodiment, unclaimed, salt, non-infringement, subject matter, dedicated, propylene, chloride, factual dispute, bendamustine, declaration, contends
Civil Procedure, Appeals, Standards of Review, De Novo Review, Judgments, Pretrial Judgments, Judgment on Pleadings, Patent Law, Doctrine of Equivalents, Elements, Equivalence, Infringement Actions, Doctrine of Equivalents, Summary Judgment, Motions for Summary Judgment, Fact & Law Issues, Evidence, Types of Evidence, Testimony, Expert Witnesses